AVITA Medical Updates Expected First Quarter 2024 Revenue

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/27/2026

1. ORCL
2. AVGO
3. CDNS
4. ANT
5. SPY
6. META
7. BA
8. HOOD
9. INTC
10. JBLU

Go back to AVITA Medical Updates Expected First Quarter 2024 Revenue

BTIG Downgrades Avita Medical Ltd. (RCEL) to Neutral

April 11, 2024 5:38 AM EDT

BTIG analyst Ryan Zimmerman downgraded Avita Medical Ltd. (NASDAQ: RCEL) from Buy to Neutral.

The analyst comments "We downgrade RCEL shares to Neutral from Buy and remove our PT. RCEL announced 1Q24 rev. is expected to be $11.0M-$11.3M, ~26.1% - 28.1% below Cons. estimates and the guidance provided on the 4Q23 call of $14.8M - $15.6M. BTIG/Street expectations going into 1Q24 were $15.2M/$15.3M. Mgmt. noted the reduction in 1Q24 guidance was due to the slower-than-expected conversion rate of new accounts for full-thickness skin defects. We model flat product... More